- Home
- NLSP vs TBI Comparison
NLSP vs TBI Comparison
Compare NLSP & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- TBI
- Stock Information
- Founded
- NLSP 2015
- TBI 1985
- Country
- NLSP Switzerland
- TBI United States
- Employees
- NLSP N/A
- TBI N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- TBI Professional Services
- Sector
- NLSP Health Care
- TBI Consumer Discretionary
- Exchange
- NLSP Nasdaq
- TBI Nasdaq
- Market Cap
- NLSP 12.4M
- TBI 169.2M
- IPO Year
- NLSP 2021
- TBI 1996
- Fundamental
- Price
- NLSP $2.10
- TBI $6.47
- Analyst Decision
- NLSP
- TBI Buy
- Analyst Count
- NLSP 0
- TBI 1
- Target Price
- NLSP N/A
- TBI $8.00
- AVG Volume (30 Days)
- NLSP 193.3K
- TBI 110.3K
- Earning Date
- NLSP 10-17-2025
- TBI 11-03-2025
- Dividend Yield
- NLSP N/A
- TBI N/A
- EPS Growth
- NLSP N/A
- TBI N/A
- EPS
- NLSP N/A
- TBI N/A
- Revenue
- NLSP N/A
- TBI $1,534,863,000.00
- Revenue This Year
- NLSP N/A
- TBI $2.21
- Revenue Next Year
- NLSP N/A
- TBI $6.18
- P/E Ratio
- NLSP N/A
- TBI N/A
- Revenue Growth
- NLSP N/A
- TBI N/A
- 52 Week Low
- NLSP $1.30
- TBI $3.45
- 52 Week High
- NLSP $6.97
- TBI $9.05
- Technical
- Relative Strength Index (RSI)
- NLSP 47.15
- TBI 59.14
- Support Level
- NLSP $1.88
- TBI $5.41
- Resistance Level
- NLSP $2.29
- TBI $6.66
- Average True Range (ATR)
- NLSP 0.13
- TBI 0.29
- MACD
- NLSP -0.00
- TBI 0.09
- Stochastic Oscillator
- NLSP 61.86
- TBI 84.80
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.